332
panel
Food Is Medicine: Opportunities to Maximize, Expand, and Scale
In September, the White House published its National Strategy on Hunger, Nutrition, and Health,
resetting the course of US food policy.
+ Read More
panel
Time=Lives and Building the Clinical Trial Enterprise of the Future
This session will open with a Time=Lives Talk by Casey McPherson, Co-Founder and Chief Innovatio
n Officer, Everlum Bio and Founder and President, To Cure A Rose Foundation, foll
+ Read More
panel
FasterCures Advisors Meeting: A Conversation with Meena Seshamani (Invite only)
This annual meeting brings together the FasterCures Advisory Groups, including the Board, Busine
ss Council, and Changemakers nonprofit advisory council, to discuss timely topics across the biomedical research ecosystem. Dr.
+ Read More
panel
Conversation with Placeholder
panel
Speakers/Moderators Declined/Cancelled
panel
Open Private Session (Invite only)
video
Regional Overview | A Conversation with His Excellency Paul Kagame, President, Republic of Rwanda
Moderator:
Michael Milken
Chairman, Milken Institute
His Excellency Paul Kagame
Presid
ent, Republic of Rwanda
+ Read More
video
Africa: The Next Frontier for Fund Investors
With a bigger landmass and a larger consumer population than India, China, the U.S., and Europe co
mbined, Africa had attracted the attention of most international investors by the early 2000s.
+ Read More
video
The Role of Technology in Global Food Security
While population growth and climate change promise to introduce profound challenges to food securi
ty around the world, countries in the Middle East are especially vulnerable.
+ Read More
video
Emerging Trends Shaping Real Estate
Shifts in consumer demand, driven by a number of variables—including geo-political tension, exchan
ge-rate volatility, and hikes in interest rates—leave the future of the global real estate market uncertain.
+ Read More
video
Blockchain and Cryptocurrency: What to Expect Next
It has been a wild ride for a cryptocurrency market that may not yet have hit bottom, scalding cou
ntless individuals and some big-name investors.
+ Read More